Literature DB >> 1449286

Clinical manifestation of mediastinal fibrosis and histoplasmosis.

D J Mathisen1, H C Grillo.   

Abstract

We treated 20 patients thought to have mediastinal fibrosis secondary to Histoplasma capsulatum. All but 1 were symptomatic. The most common symptoms were dyspnea (8), hemoptysis (6), postobstructive pneumonia (5), and superior vena caval obstruction (2). Nine patients had severe stenosis of the trachea, carina, or main bronchus. Special stains identified Histoplasma capsulatum in surgical specimens in 9 patients. Surgical procedures were done for 18 of 20 patients (resection of subcarinal mass, 6; right middle and lower lobectomy, 5; carinal pneumonectomy, 4; esophagoplasty, 4; sleeve resection, 3 (with right main bronchus in 1, right lower and middle lobectomy in 1, and carina in 1); right upper lobectomy, 1; middle lobectomy, 1; and bronchoplasty of left main bronchus, 1. There were 4 deaths, 3 after complications of carinal pneumonectomy and 1 in a patient with tracheobronchial obstruction that could not be dilated. Two patients were treated with amphotericin and 4 with ketoconazole. Sclerosing mediastinitis secondary to histoplasmosis presents tremendous surgical challenges because of the intense fibrosis encountered. Bronchoplastic procedures are possible in spite of the intense fibrosis. High mortality rates after carinal resection may be encountered. The exact role of antifungal therapy is as yet undefined.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1449286     DOI: 10.1016/0003-4975(92)90069-g

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  20 in total

Review 1.  Surgical management of non-mycobacterial fungal infections.

Authors:  Staci Beamer
Journal:  J Thorac Dis       Date:  2018-10       Impact factor: 2.895

Review 2.  Histoplasmosis: a clinical and laboratory update.

Authors:  Carol A Kauffman
Journal:  Clin Microbiol Rev       Date:  2007-01       Impact factor: 26.132

3.  Idiopathic mediastinal fibrosis: report of a case.

Authors:  S Kinugasa; S Tachibana; M Kawakami; T Orino; R Yamamoto; S Sasaki
Journal:  Surg Today       Date:  1998       Impact factor: 2.549

4.  DIAGNOSIS OF HISTOPLASMOSIS.

Authors:  Allan Jefferson Guimarães; Joshua D Nosanchuk; Rosely Maria Zancopé-Oliveira
Journal:  Braz J Microbiol       Date:  2006-01       Impact factor: 2.476

5.  Fibrosingmediastinitis and consequent superior vena cava syndrome - A case report.

Authors:  Saumitra Kant; Garrett L Walsh
Journal:  J Thorac Dis       Date:  2012-08       Impact factor: 2.895

6.  Percutaneous vascular stent implantation as treatment for central vascular obstruction due to fibrosing mediastinitis.

Authors:  Erin L Albers; Meredith E Pugh; Kevin D Hill; Li Wang; James E Loyd; Thomas P Doyle
Journal:  Circulation       Date:  2011-03-21       Impact factor: 29.690

Review 7.  Idiopathic Mediastinal Fibrosis: a Systemic Immune-Mediated Disorder. A Case Series and a Review of the Literature.

Authors:  Giovanni M Rossi; Giacomo Emmi; Domenico Corradi; Maria L Urban; Federica Maritati; Federica Landini; Paola Galli; Alessandra Palmisano; Augusto Vaglio
Journal:  Clin Rev Allergy Immunol       Date:  2017-06       Impact factor: 8.667

Review 8.  Balloon angioplasty or stent implantation for pulmonary vein stenosis caused by fibrosing mediastinitis: a systematic review.

Authors:  Yichao Duan; Xing Zhou; Hongling Su; Kaiyu Jiang; Wenyu Wu; Xin Pan; Guanming Qi; Yan Zhang; Yunshan Cao
Journal:  Cardiovasc Diagn Ther       Date:  2019-10

9.  Pulmonary Histoplasmosis.

Authors:  Carol A. Kauffman
Journal:  Curr Infect Dis Rep       Date:  2001-06       Impact factor: 3.725

Review 10.  [Treatment of chronic mediastinitis].

Authors:  R Scheubel
Journal:  Chirurg       Date:  2016-06       Impact factor: 0.955

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.